Compare Moderna, Inc. (MRNA) vs Veritone Inc (VERI) Price & Performance

Moderna, Inc.Trade

Veritone IncTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Veritone Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Veritone Inc trades at $1.13 (market cap $97.60M). The key difference: Moderna, Inc. is far larger — about 241.8× Veritone Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.

	MRNA	VERI
Market Cap	$23.60B	$97.60M
Sector	Health	Technology
52-Week High	$81.80	$8.39
52-Week Low	$22.36	$1.02
Enterprise Value	$19.70B	$129.63M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

VERI

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Veritone Inc

Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.